ArcticZymes Investor Relations Material
Latest events
Q4 2023
ArcticZymes
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ArcticZymes Technologies
Access all reports
Segment Data
Access more data
Sales revenue by
Business area
Enzymes
Expenses by
Financials
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and markets recombinant enzymes derived from cold-water marine species and organisms from other relevant environments for use in molecular research, in vitro diagnostics, and therapeutics in Norway, Europe, Asia, Australia, Africa, and the Americas. It provides enzymes for real-time PCR; enzymes for various applications; Norzym Taq DNA Polymerase for routine PCR applications; Menthazym Taq DNA Polymerase that enables amplification of DNA in low-copy templates; Toyzym Taq DNA Polymerase that enhances PCR sensitivity and specificity; MgGapFill DNTP Mix that produces more reliable qPCR results by maximizing efficiency and reducing nonspecific amplifications; and ZymoTaq Hotstart qPCR Mix that provides speed and convenience with the increased specificity of hot-start chemistry.
Key slides for ArcticZymes Technologies
Q4 2023
ArcticZymes Technologies
Q4 2023
ArcticZymes Technologies
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇳🇴 Norway